1 Department of Preclinical Veterinary Sciences, Royal (Dick) School of
Veterinary Studies, Summerhall Square, Edinburgh EH9 1QH, Scotland
2 Rinat Neuroscience Corporation, 3155 Porter Drive, Palo Alto, CA 94304-1213,
USA
3 Department of Veterinary Science, Pennsylvania State University, University
Park, PA 16802-3500, USA
* Author for correspondence (e-mail: davies{at}rinatneuro.com)
Accepted 19 November 2002
![]() |
SUMMARY |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: Mouse, Neuron, MSP
![]() |
INTRODUCTION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
MSP exerts its actions on responsive cells by binding to the receptor
tyrosine kinase Ron (Mst1r Mouse Genome Informatics), which is
structurally related to the HGF receptor tyrosine kinase Met
(Bottaro et al., 1991;
Naldini et al., 1991
;
Gaudino et al., 1994
;
Wang et al., 1994
). To
investigate whether MSP is a neurotrophic factor for developing neurons, we
have investigated its actions on sensory and sympathetic neurons cultured at
stages throughout their development, and have studied the expression of RON
mRNA and MSP mRNA in these neurons and their targets over the same period. We
focused on four neuronal populations, the neurotrophic factor requirements of
which are very well characterized in the developing mouse. The sensory neurons
of the trigeminal and dorsal root ganglia (DRG) are mostly dependent on a
supply of NGF from their peripheral targets during the phase of naturally
occurring neuronal death (Buchman and
Davies, 1993
; Memberg and
Hall, 1996
;
Piñón et al.,
1996
). The sympathetic neurons of the superior cervical ganglion
(SCG) are dependent on the supply of both NGF and NT3 during this phase of
development (Francis et al.,
1999
; Wyatt et al.,
1997
). The sensory neurons of the nodose ganglion depend on BDNF,
NT3 or NT4 for survival (ElShamy and
Ernfors, 1997
) and contain very few NGF-dependent neurons
(Forgie et al., 2000
). We
report that MSP has potent and distinctive, age-related effects on the
survival and growth of NGF-dependent neurons, and show that MSP mRNA is
expressed in tissues innervated by MSP-dependent neurons.
![]() |
MATERIALS AND METHODS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
To estimate of the number of neurons surviving under different experimental conditions, the number of attached neurons within a 12x12 mm grid in the center of each petri dish was counted 6 hours after plating and was counted again at 48 hours. The number of neurons at 48 hours is expressed as a percentage of the 6 hour count.
To quantify the number of new neurons generated in E14 SCG cultures, an
initial cohort that comprised all of the neurons within a 12x12 mm grid
was identified 6 hours after plating. The survival of each of these neurons
was monitored at 6 hourly intervals and the number of new neurons generated in
the same grid was monitored at each time point. The total number of new
neurons generated over time in these cultures is expressed as a percentage of
the size of the initial cohort. BrdU incorporation into the nuclei of
proliferating neuroblasts in E14 SCG cultures was determined
immunocytochemically as described previously
(Wyatt et al., 1999).
Neurite length was quantified for cultured embryonic neurons by making
drawings of neurons with the aid of a drawing tube from which measurements
were subsequently made with the aid of a computer-linked digitizing tablet
(Davies, 1989). More than 150
neurons were drawn and analyzed for each experimental condition. For the
extensive and highly branched neurite arbors of P1 DRG neurons, we used an
interactive stereological approach in which the extent of neurite growth was
calculated from the frequency at which neurites intersected a series of
randomly oriented, computer-generated lines (Kinetics Imaging).
Measurement of MSP and Ron mRNA levels
A quantitative reverse transcription-polymerase chain reaction (RT-PCR)
technique (Wyatt and Davies,
1993) was used to measure the levels of MSP and Ron mRNAs in RNA
from dissected tissues or purified neurons. The levels of mRNA for the
housekeeping protein GAPDH were also determined by quantitative RT-PCR,
allowing MSP and Ron mRNA expression to be calculated relative to GAPDH mRNA.
The RT- PCR reactions were calibrated by the inclusion of known amounts of
cRNA competitor templates for each of the mRNAs in the reverse transcription
reaction.
The forward primer for assaying MSP cDNA was 5'-ACC CAG CAC TCG CTG
CAC ACA C-3' and the reverse primer was 5'-TCT GGA AGA GAT GGC ACA
GAC TCG-3'. These hybridize 60 bp apart in mouse MSP cDNA and 63 bp
apart in the MSP competitor cDNA. The forward primer for amplifying Ron was
5'-ACT GTC ATT TTG CAC CTA AAC GC-3' and the reverse primer was
5'-AGT GGG CTG CCT GAA GCA CTG-3'. These hybridize 80 bp apart in
mouse RON cDNA and 82 bp apart in the RON competitor cDNA. The details of the
GAPDH RT-PCR assay and amplification conditions are described elsewhere
(Wyatt et al., 1997).
MSP cDNA was amplified by 38 to 40 cycles at 91°C for 60 seconds, 64°C for 45 seconds and 72°C for 60 seconds. Ron cDNA was amplified by 37 cycles of 91°C for 60 seconds, 56°C for 45 seconds and 72°C for 60 seconds. The RT-PCR products of the native MSP, Ron and GAPDH mRNAs, and those of the cRNA competitor species were separated on 8% non-denaturing polyacrylamide gels. These gels were subsequently stained with SyberGold (Cambridge Biosciences) and the intensity of the RT-PCR products were determined using a gel documentation system (Biogene) with Phoretix software.
Quantification of the number of neurons in trigeminal and nodose
ganglia
The heads of newborn and P6 pups in litters resulting from matings of
Ron+/- mice (Correll et
al., 1997) were fixed in neutral buffered formalin, decalcified,
paraffin wax embedded and serially sectioned at 8 µm through the trigeminal
and nodose ganglia. The sections were then stained with Cresyl Fast Violet and
neuronal number was quantified using a digital stereology system that employs
a combination of the optical dissector and volume fraction/Cavalieri methods
(Kinetic Imaging).
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
|
To further characterize the survival-enhancing effects of MSP on developing DRG neurons, we studied the dose-response relationship between these neurons and MSP at different developmental stages. These experiments not only showed that MSP promoted the survival of increasing numbers of DRG with age, but that the neurons became increasingly sensitive to MSP with age. The MSP dose-response curve exhibited a marked shift to the left between E12 and P1 (Fig. 2). Interpolation of the data revealed an approximate 25-fold decrease in the EC50 over this period of development.
|
We also studied the effect of MSP on trigeminal ganglion neurons, a population of cutaneous sensory neurons that also contains a large proportion of NGF-dependent neurons. Fig. 3 shows that the effectiveness with which MSP promoted the survival of these neurons also increased with age: from less than 5% survival in E12 cultures to 65% of the number of neurons surviving with NGF by P1 (Fig. 3). During this period of development, NGF promoted the survival of the majority of the neurons. As in DRG cultures, the number of neurons that survived with MSP plus NGF was not significantly greater than the number surviving with NGF alone (P>0.05, t-test), indicating that MSP promotes the survival of an increasing proportion of NGF-responsive neurons in the trigeminal ganglion with age. In contrast to DRG and trigeminal neurons, the survival of nodose ganglion neurons in the presence of 10 or 50 ng/ml of MSP was not significantly greater than controls at E14, E16 or P1 (data not shown).
|
MSP is an early survival factor for a subset of sympathetic
neurons
To investigate if MSP influences sympathetic neuron survival, we
established low density SCG cultures at stages from E14 (when the SCG still
contains many proliferating neuroblasts and immature neurons that survive for
several days without added neurotrophic factors) to P1 (when most of the
neurons have become dependent on NGF for survival). In marked contrast to
sensory neurons, sympathetic neurons showed a survival response to MSP that
decreased with age. In E14 cultures, there were 20% more neurons surviving
with MSP than in control cultures. By E17, there were fewer than 10% more
neurons with MSP, and by P1 there were almost no neurons with MSP. There was
no significant difference between the number of neurons with MSP plus NGF
compared with the number with NGF alone (P>0.05, t-test).
Dose-response analysis showed that the maximally effective concentration of
MSP for E14 SCG survival was 10 ng/ml (Fig.
4), the same concentration that is maximally effective for P1 DRG
neuron survival (Fig. 2).
|
Because the E14 SCG contains many proliferating neuroblasts that differentiate into neurons in culture, we carried out additional experiments to determine if the increased number of neurons in MSP supplemented cultures was due to increased neurogenesis. We estimated the number of new neurons generated over time in culture by identifying all of the neuroblasts and neurons in a grid in the center of culture dishes 6 hours after plating. By following the fate of each of these neurons at six hourly intervals, we were able to recognize and count all new neurons that were generated in this grid over time. These experiments showed that there was no significant difference in the total number of new neurons that were generated between 6 and 48 hours (expressed as a percentage of the initial 6 hour cohort) in control cultures and cultures supplemented with MSP (12.1±0.4% and 13.1±1.2%, respectively, n=3 experiments, P>0.05). These cohort experiments, however, revealed that MSP enhanced the survival of post-mitotic neurons. Immunocytochemical measurement of BrdU incorporation in these cultures also revealed no significant difference between the numbers of BrdU-positive cells in control and MSP-supplemented cultures (20.9±1.4% and 22.7±1.3%, respectively, after 18 hours incubation with BrdU, n=3 experiments, P>0.05). These results show that MSP neither promotes sympathetic neuroblast proliferation nor enhances sympathetic neuron generation, and demonstrate that the reason for the increased number of neurons in early SCG cultures is due to a survival effect of MSP on newly differentiated, post-mitotic sympathetic neurons.
MSP enhances neurite growth from sensory and sympathetic neurons
To investigate the effects of MSP on neurite growth it was essential to
compare the same subset of neurons with and without MSP. Because
MSP-responsive neurons comprise a subset of NGF-responsive neurons, we grew
neurons with NGF in the presence or absence of MSP and estimated the total
length and number of branch points in the neurite arbors that grew from the
neurons. Fig. 5 shows that in
P1 DRG cultures after just 24 hours incubation, MSP promoted a 38% increase in
the average length of neurite arbors and a 39% increase in branch point
number. Although there was no significant effect of MSP on the growth of P1
SCG neuron arbors (data not shown), in E14 SCG cultures, MSP promoted a small,
statistically significant increase in neurite length (3.65±0.16 mm
versus 4.21±0.16 mm with NGF and NGF+MSP, respectively,
P<0.01) and branching (5.20±0.32 versus 6.03±0.35
branches with NGF and NGF+MSP, respectively, P<0.05) after 48
hours incubation. These results show that MSP enhances the growth and
branching of sensory and sympathetic neurites during the stages of development
when these neurons survive with MSP.
|
MSP mRNA and Ron mRNA in neurons and their targets
To ascertain the source of MSP for developing sensory neurons in vivo, we
used competitive RT-PCR to measure the level of MSP mRNA in the trigeminal
ganglion and a well defined part of its cutaneous territory at stages
throughout its innervation. The earliest trigeminal axons reach the maxillary
process by E11, and over the next 5 days this structure and the mystacial
whisker pad that develops from it becomes the most densely innervated
cutaneous tissue in the mouse embryo
(Davies and Lumsden, 1984).
MSP mRNA was detected in the maxillary territory as early as E12 and its level
increased markedly with age as trigeminal neurons become responsive to MSP and
their axons reach and ramify within this tissue
(Fig. 6). By contrast, the
level of MSP mRNA in the iris, a structure that receives a dense sympathetic
innervation from the SCG, was initially high during the earliest stages of its
innervation, but subsequently fell markedly later in embryonic development.
Compared with the high levels of MSP mRNA in the target fields of sensory and
sympathetic neurons at the stages of development when these neurons are most
sensitive to MSP, the levels of MSP mRNA in the trigeminal ganglia and SCG
were negligible. Moreover, in contrast to the marked developmental changes in
MSP mRNA in target tissues, there were no developmental changes in MSP mRNA
expression in these ganglia. These results suggest MSP is a target-derived
neurotrophic factor for sensory and sympathetic neurons at different stages of
target field innervation.
|
RT-PCR analysis revealed that developing trigeminal ganglia and SCG both
express Ron mRNA. Because at E16 and later there is a sufficient size
difference between neurons and non-neuronal cells in the trigeminal ganglion
to permit neuronal purification by differential sedimentation
(Davies, 1986), we were able to
show that neuronal expression of Ron mRNA increases from E16 to P1 as neurons
become more sensitive to MSP (53.2±9.7 and 122.3±18.7 fg Ron
mRNA per pg GAPDH mRNA at E16 and P1, respectively, n=3).
Furthermore, we also compared the relative levels of Ron mRNA in whole DRG,
SCG and nodose ganglia at P1 by semiquantitative RT/PCR. Compared with the
level of Ron mRNA in MSP-responsive DRG, the levels of Ron mRNA in the SCG and
nodose ganglia were much lower (relative to GAPDH mRNA levels, the levels of
Ron mRNA in the SCG and nodose ganglia were a half and one fifth the level in
the DRG, respectively). Thus, ganglia that contain large numbers of neurons
that survive in response to MSP contain relatively higher levels of Ron mRNA
than ganglia that contain few MSP-responsive neurons.
Reduction of sensory neurons in mice with defective MSP
signaling
To ascertain the physiological relevance of our in vitro findings, we
studied the in vivo consequences of defective MSP signaling via its specific
receptor tyrosine kinase Ron. Because complete elimination of Ron leads to
early embryonic death (Muraoka et al.,
1999), we studied mice with a targeted deletion of the
ligand-binding domain (Correll et al.,
1997
). Although these mice do not express the Ron receptor on the
cell surface, they possess a truncated receptor consisting of the
transmembrane and tyrosine kinase domains whose expression is driven by an
internal promoter (Correll et al.,
1997
; Persons et al.,
1999
). Mice homozygous for this mutant survive into adulthood with
deregulated inflammatory responses caused by impaired MSP signaling in
macrophages (Correll et al.,
1997
; Morrison and Correll,
2002
; Lutz et al.,
2002
).
We compared the number of neurons in the trigeminal ganglia
Ron-/- and wild-type mice in newborn and P6 neonates
(Fig. 7). In newborn mice,
there were no fewer neurons in Ron-/- mice than in wild
types. However, between P1 and P6 there was a highly significant 25% decrease
in the number of neurons in the trigeminal ganglia of
Ron-/- mice (P<0.001, t-test),
whereas over the same period of development there was no significant change in
the number of neurons in Ron+/+ mice (<1% decrease,
P>0.05, t-test), and at P6 there were significantly fewer
neurons in the trigeminal ganglia of Ron-/- mice compared
with Ron+/+ mice (P< 0.01, t-test).
Although there appear to be more neurons in the trigeminal ganglia of
Ron-/- mice compared with Ron+/+ mice,
this difference was not statistically significant (P>0.05). Taken
together, these data suggest that neurons are lost in the trigeminal ganglia
of Ron-/- mice in the postnatal period, implying that
MPS/Ron signaling is important for sustaining the survival of a subset of
these neurons in vivo after the period of naturally occurring neuronal death
that is over by birth (Davies and Lumsden,
1984). To ascertain whether the loss of trigeminal neurons in the
postnatal period in Ron-/- mice is specific for
MSP-responsive neurons or is a consequence of a generalized effect of
defective Ron signaling on neuronal survival, we compared the number of
neurons in the nodose ganglion of P6 wild type and Ron-/-
mice. In accordance with the lack of MSP on the in vitro survival of embryonic
and postnatal nodose neurons, there were no fewer neurons in the nodose
ganglia of Ron-/- mice than wild-type mice at P6
(Fig. 7).
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
The level of MSP mRNA increases in the maxillary territory of the
trigeminal ganglion over the same period of development as trigeminal neurons
acquire responsiveness to MSP, reaching a plateau by P1 when the neurons have
become maximally responsive to this factor. Because the level of MSP mRNA is
negligible in the trigeminal ganglion, these results suggest that MSP is, like
NGF, a target-derived neurotrophic factor for a subset of cutaneous sensory
neurons. The level of NGF mRNA also increases in the maxillary territory
during its innervation by the trigeminal ganglion, but reaches a plateau at
E15 (Davies et al., 1987),
several days before the level of MSP mRNA reaches its plateau. This sequential
rise in the expression of NGF and MSP mRNAs in the trigeminal territory
accords with the sequential development of NGF and MSP responsiveness with
age.
Although NGF is capable of promoting the survival of the majority of
trigeminal neurons in culture throughout the period of naturally occurring
neuronal death, the NGF dose-response curve shifts by over an order of
magnitude to higher NGF concentrations during this period of development,
indicating that the neurons become much less sensitive to NGF with age
(Buchman and Davies, 1993).
This observation, together with our finding that sensory neurons become much
more sensitive to MSP over the same period of development, suggests a
developmental switch in responsiveness from NGF to MSP during development.
Indeed, the finding that the great majority of trigeminal neurons die by E15
in mice that lack functional TrkA receptors (Piñón et al., 1999)
suggests that NGF/TrkA signaling is particularly important for sustaining
neuronal survival during the early stages of naturally occurring neuronal
death.
The concept of neurotrophic factor switching originated from work on the
early mouse trigeminal system, and has since been observed in several other
populations of neurons. Most E10 and E11 trigeminal neurons survive in culture
with BDNF and very few survive with NGF, whereas by E12 most neurons survive
with NGF and very few survive with BDNF
(Buchman and Davies, 1993;
Paul and Davies, 1995
).
Although this switch in responsiveness is due in part to the sequential
generation of BDNF-responsive and NGF-responsive neurons
(Enokido et al., 1999
;
Huang et al., 1999
), many of
the neurons that initially survive with BDNF subsequently switch to become
NGF-responsive (Enokido et al.,
1999
). Thus, in the trigeminal ganglion, there appears to be a
switch from BDNF to NGF dependence early in development followed by a later
shift in responsiveness from NGF to MSP during the period of naturally
occurring neuronal death.
In contrast to developing sensory neurons, sympathetic neurons exhibit a transient survival response to MSP shortly after they differentiate from their precursor cells, but not at later stages during the phase of naturally occurring neuronal death. Accordingly, MSP mRNA is expressed at high levels in the iris, a densely innervated sympathetic target, at this early stage in development, and its expression decreases markedly with age. These findings raise the possibility that MSP is required to sustain the survival of a subset of sympathetic neurons during the early stages of target field innervation.
MSP is structurally related to HGF, a pleiotropic factor that has a well
established neurotrophic factor role in the developing nervous system
(Ebens et al., 1996;
Hamanoue et al., 1996
;
Maina et al., 1997
;
Maina et al., 1998
;
Yamamoto et al., 1997
;
Wong et al., 1997
;
Yang et al., 1998
;
Davey et al., 2000
;
Okura et al., 1999
;
Novak et al., 2000
). However,
the neurotrophic actions of HGF differ in an important respect from those of
MSP. Whereas HGF generally only enhances neuronal survival in the presence of
other neurotrophic factors, MSP increases the survival of sensory and
sympathetic neurons in the absence of other neurotrophic factors. Moreover,
for sensory neurons at least, MSP is a far more effective and potent
neurotrophic factor than HGF. MSP has also recently been shown to promote the
survival of embryonic hypoglossal motoneurons
(Schmidt et al., 2002
) and
sustain cholinergic acetyltransferase expression in these neurons after
axotomy in the adult (Stella et al.,
2001
).
In summary, we have shown that MSP is a target-derived neurotrophic factor that promotes the survival and growth of sensory and sympathetic neurons at defined stages in their development. Its neurotrophic effects differ from those of the structurally related factor HGF in having direct survival-promoting effects independently of the presence of other factors.
![]() |
ACKNOWLEDGMENTS |
---|
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Banu, N., Price, D. J., London, R., Deng, B., Mark, M., Godowski, P. J. and Avraham, H. (1996). Modulation of megakaryocytopoiesis by human macrophage-stimulating protein, the ligand for the RON receptor. J. Immunol. 156,2933 -2940.[Abstract]
Birchmeier, C. and Gherardi, E. (1998). Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol. 8,404 -410.[CrossRef][Medline]
Bottaro, D. P., Rubin, J. S., Faletto, D. L., Chan, A. M., Kmiecik, T. E., Vande Woude, G. F. and Aaronson, S. A. (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251,802 -804.[Medline]
Broxmeyer, H. E., Cooper, S., Li, Z. H., Lu, L., Sarris, A., Wang, M. H., Chang, M. S., Donner, D. B. and Leonard, E. J. (1996). Macrophage-stimulating protein, a ligand for the RON receptor protein tyrosine kinase, suppresses myeloid progenitor cell proliferation and synergizes with vascular endothelial cell growth factor and members of the chemokine family. Ann. Hematol. 73, 1-9.[CrossRef][Medline]
Buchman, V. L. and Davies, A. M. (1993).
Different neurotrophins are expressed and act in a developmental sequence to
promote the survival of embryonic sensory neurons.
Development 118,989
-1001.
Correll, P. H., Iwama, A., Tondat, S., Mayrhofer, G., Suda, T. and Bernstein, A. (1997). Deregulated inflammatory response in mice lacking the STK/RON receptor tyrosine kinase. Genes Funct. 1,69 -83.[Medline]
Davey, F., Hilton, M. and Davies, A. M. (2000). Co-operation between HGF and CNTF in promoting the survival and growth of sensory and parasympathetic neurons. Mol. Cell. Neurosci. 15,79 -87.[CrossRef][Medline]
Davies, A. M. (1986). The survival and growth of embryonic proprioceptive neurons is promoted by a factor present in skeletal muscle. Dev. Biol. 115, 56-67.[Medline]
Davies, A. M. (1989). Intrinsic differences in the growth rate of early nerve fibres related to target distance. Nature 337,553 -555.[CrossRef][Medline]
Davies, A. M. (1994). Role of neurotrophins in the developing nervous system. J. Neurobiol. 25,1334 -1348.[Medline]
Davies, A. M. and Lumsden, A. G. S. (1984). Relation of target encounter and neuronal death to nerve growth factor responsiveness in the developing mouse trigeminal ganglion. J. Comp. Neurol. 223,124 -137.[Medline]
Davies, A. M., Bandtlow, C., Heumann, R., Korsching, S., Rohrer, H. and Thoenen, H. (1987). Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor. Nature 326,353 -358.[CrossRef][Medline]
Davies, A. M., Lee, K. F. and Jaenisch, R. (1993). p75-deficient trigeminal sensory neurons have an altered response to NGF but not to other neurotrophins. Neuron 11,565 -574.[Medline]
Ebens, A., Brose, K., Leonardo, E. D., Hanson, M. G., Bladt, F., Birchmeier, C., Barres, B. A. and Tessier-Lavigne, M. (1996). Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons. Neuron 17,1157 -1172.[Medline]
ElShamy, W. M. and Ernfors, P. (1997).
Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4
complement and cooperate with each other sequentially during visceral neuron
development. J. Neurosci.
17,8667
-8675.
Enokido, Y., Wyatt, S. and Davies, A. M.
(1999). Developmental changes in the response of trigeminal
neurons to neurotrophins: Influence of birthdate and the ganglion environment.
Development 126,4365
-4373.
Forgie, A., Wyatt, S., Kuehnel, F. and Davies, A. M. (2000). In vivo survival requirement of a subset of nodose ganglion neurons for nerve growth factor. Eur. J. Neurosci. 12,670 -676.[CrossRef][Medline]
Francis, N., Farinas, I., Brennan, C., Rivas-Plata, K., Backus, C., Reichardt, L. and Landis, S. (1999). NT-3, like NGF, is required for survival of sympathetic neurons, but not their precursors. Dev. Biol. 210,411 -427.[CrossRef][Medline]
Gaudino, G., Follenzi, A., Naldini, L., Collesi, C., Santoro, M., Gallo, K. A., Godowski, P. J. and Comoglio, P. M. (1994). RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP. EMBO J. 13,3524 -3532.[Abstract]
Hamanoue, M., Takemoto, N., Matsumoto, K., Nakamura, T., Nakajima, K. and Kohsaka, S. (1996). Neurotrophic effect of hepatocyte growth factor on central nervous system neurons in vitro. J. Neurosci. Res. 43,554 -564.[CrossRef][Medline]
Huang, E. J., Wilkinson, G. A., Farinas, I., Backus, C., Zang,
K., Wong, S. L. and Reichardt, L. F. (1999). Expression of
Trk receptors in the developing mouse trigeminal ganglion: in vivo evidence
for NT-3 activation of TrkA and TrkB in addition to TrkC.
Development 126,2191
-2203.
Ibanez, C. F. (1998). Emerging themes in structural biology of neurotrophic factors. Trends Neurosci. 21,438 -444.[CrossRef][Medline]
Kurihara, N., Tatsumi, J., Arai, F., Iwama, A. and Suda, T. (1998). Macrophage-stimulating protein (MSP) and its receptor, RON, stimulate human osteoclast activity but not proliferation: effect of MSP distinct from that of hepatocyte growth factor. Exp. Hematol. 26,1080 -1085.[Medline]
Leonard, E. J. and Skeel, A. H. (1978). Isolation of macrophage stimulating protein (MSP) from human serum. Exp. Cell Res. 114,117 -126.[Medline]
Lewin, G. R. and Barde, Y. A. (1996). The physiology of Neurotrophins. Annu. Rev. Neurosci. 19,289 -317.[CrossRef][Medline]
Lutz, M. A., Gervais, F., Bernstein, A., Hattel, A. L. and
Correll, P. H. (2002). STK receptor tyrosine kinase regulates
susceptibility to infection with Listeria monocytogenes. Infect.
Immun. 70,416
-418.
Maina, F. and Klein, R. (1999). Hepatocyte growth factor, a versatile signal for developing neurons. Nat. Neurosci. 2,213 -217.[CrossRef][Medline]
Maina, F., Hilton, M. C., Ponzetto, C., Davies, A. M. and Klein,
R. (1997). Met receptor signalling is required for sensory
nerve development. Genes Dev.
11,3341
-3350.
Maina, F., Hilton, M. C., Andres, R., Wyatt, S., Klein, R. and Davies, A. M. (1998). Multiple roles for hepatocyte growth factor in sympathetic neuron development. Neuron 20,835 -846.[Medline]
Memberg, S. P. and Hall, A. K. (1996). Proliferation, differentiation, and survival of rat sensory neuron precursors in vitro require specific trophic factors. Mol. Cell. Neurosci. 6,323 -335.[CrossRef]
Morrison, A. C. and Correll, P. H. (2002).
Activation of the stem cell-derived tyrosine kinase/RON receptor tyrosine
kinase by macrophage-stimulating protein results in the induction of arginase
activity in murine peritoneal macrophages. J. Immunol.
168,853
-860.
Muraoka, R. S., Sun, W. Y., Colbert, M. C., Waltz, S. E., Witte,
D. P., Degen, J. L. and Friezner Degen, S. J. (1999). The
Ron/STK receptor tyrosine kinase is essential for peri-implantation
development in the mouse. J. Clin. Invest.
103,1277
-1285.
Naldini, L., Vigna, E., Narsimhan, R. P., Gaudino, G., Zarnegar, R., Michalopoulos, G. K. and Comoglio, P. M. (1991). Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 6, 501-504.[Medline]
Novak, K. D., Prevette, D., Wang, S., Gould, T. W. and
Oppenheim, R. W. (2000). Hepatocyte growth factor/scatter
factor is a neurotrophic survival factor for lumbar but not for other somatic
motoneurons in the chick embryo. J. Neurosci.
20,326
-337.
Okura, Y., Arimoto, H., Tanuma, N., Matsumoto, K., Nakamura, T., Yamashima, T., Miyazawa, T. and Matsumoto, Y. (1999). Analysis of neurotrophic effects of hepatocyte growth factor in the adult hypoglossal nerve axotomy model. Eur. J. Neurosci. 11,4139 -4144.[CrossRef][Medline]
Paul, G. and Davies, A. M. (1995). Trigeminal sensory neurons require extrinsic signals to switch neurotrophin dependence during the early stages of target field innervation. Dev. Biol. 171,590 -605.[CrossRef][Medline]
Persons, D. A., Paulson, R. F., Loyd, M. R., Herley, M. T., Bodner, S. M., Bernstein, A., Correll, P. H. and Ney, P. A. (1999). Fv2 encodes a truncated form of the Stk receptor tyrosine kinase. Nat. Genet. 23,159 -165.[CrossRef][Medline]
Piñón, L. G. P., Minichiello, L., Klein, R. and
Davies, A. M. (1996). Timing of neuronal death in trkA,
trkB and trkC mutant embryos reveals developmental changes in
sensory neuron dependence on Trk signalling.
Development 122,3255
-3261.
Schmidt, O., Doxakis, E. and Davies, A. M. (2002). Macrophage stimulating protein is a novel neurotrophic factor for embryonic chicken hypoglossal motoneurons. Eur. J. Neurosci. 15,101 -108.[CrossRef][Medline]
Skeel, A. and Leonard, E. J. (1994). Action and
target cell specificity of human macrophage-stimulating protein (MSP).
J. Immunol. 152,4618
-4623.
Stella, M. C., Vercelli, A., Repici, M., Follenzi, A. and
Comoglio, P. M. (2001). Macrophage stimulating protein is a
novel neurotrophic factor. Mol. Biol. Cell
12,1341
-1352.
Wang, M. H., Dlugosz, A. A., Sun, Y., Suda, T., Skeel, A. and Leonard, E. J. (1996). Macrophage-stimulating protein induces proliferation and migration of murine keratinocytes. Exp. Cell Res. 226,39 -46.[CrossRef][Medline]
Wang, M. H., Ronsin, C., Gesnel, M. C., Coupey, L., Skeel, A., Leonard, E. J. and Breathnach, R. (1994). Identification of the ron gene product as the receptor for the human macrophage stimulating protein. Science 266,117 -119.[Medline]
Wong, V., Glass, D. J., Arriaga, R., Yancopoulos, G. D.,
Lindsay, R. M. and Conn, G. (1997). Hepatocyte growth factor
promotes motor neuron survival and synergizes with ciliary neurotrophic
factor. J. Biol. Chem.
272,5187
-5191.
Wyatt, S. and Davies, A. M. (1993). Regulation
of expression of mRNAs encoding the nerve growth factor receptors p75 and trkA
in developing sensory neurons. Development
119,635
-648.
Wyatt, S., Piñón, L. G. P., Ernfors, P. and
Davies, A. M. (1997). Sympathetic neuron survival and TrkA
expression in NT3-deficient mouse embryos. EMBO J.
16,3115
-3123.
Wyatt, S., Andres, R., Rohrer, H. and Davies, A. M.
(1999). Regulation of neurotrophin receptor expression by
retinoic acid in mouse sympathetic neuroblasts. J.
Neurosci. 19,1062
-1071.
Yamamoto, Y., Livet, J., Pollock, R. A., Garces, A., Arce, V.,
deLapeyriere, O. and Henderson, C. E. (1997). Hepatocyte
growth factor (HGF/SF) is a muscle-derived survival factor for a subpopulation
of embryonic motoneurons. Development
124,2903
-2913.
Yang, X. M., Toma, J. G., Bamji, S. X., Belliveau, D. J., Kohn,
J., Park, M. and Miller, F. D. (1998). Autocrine hepatocyte
growth factor provides a local mechanism for promoting axonal growth.
J. Neurosci. 18,8369
-8381.
Yoshimura, T., Yuhki, N., Wang, M. H., Skeel, A. and Leonard, E.
J. (1993). Cloning, sequencing, and expression of human
macrophage stimulating protein (MSP, MST1) confirms MSP as a member of the
family of kringle proteins and locates the MSP gene on chromosome 3.
J. Biol. Chem. 268,15461
-15468.